The burgeoning landscape of emerging treatments for weight management has seen the rise of both retatrutide and tirzepatide, both dual approach agonists targeting the GLP-1 and GIP receptors. While sharing a similar https://cyruswavi687595.wikiexpression.com/5691576/retatrutide_vs_tirzepatide_a_comparative_analysis